Chief Financial Officer at Eli Lilly And Co (LLY) Buys $20k in Stock
Joshua L Smiley, Senior Vice President and Chief Financial Officer at Eli Lilly And Co (LLY), bought 185 shares of the company’s common stock on Jul 15. At $108.47 per share, Smiley paid a total of $20,067 for the new shares.
Already a member?
Login to see your Insider Activity Trade Idea.
Not yet a member?
You can receive four timely bull-put credit spreads each market day by joining our InvestorsKeyhole Daily Trade Alerts Service. Our analysts scour the news looking for unusual options activity, how insiders are trading, and breaking news, and publish trades accordingly.
Become A Member
About Eli Lilly and Company
Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.